SG11201811070SA - Exosome-guided treatment of cancer - Google Patents

Exosome-guided treatment of cancer

Info

Publication number
SG11201811070SA
SG11201811070SA SG11201811070SA SG11201811070SA SG11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA
Authority
SG
Singapore
Prior art keywords
exosome
cancer
guided treatment
guided
treatment
Prior art date
Application number
SG11201811070SA
Other languages
English (en)
Inventor
Patrick Soon-Shiong
Original Assignee
Nant Holdings Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nant Holdings Ip Llc filed Critical Nant Holdings Ip Llc
Publication of SG11201811070SA publication Critical patent/SG11201811070SA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SG11201811070SA 2016-06-21 2017-06-21 Exosome-guided treatment of cancer SG11201811070SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662352753P 2016-06-21 2016-06-21
PCT/US2017/038515 WO2017223186A1 (en) 2016-06-21 2017-06-21 Exosome-guided treatment of cancer

Publications (1)

Publication Number Publication Date
SG11201811070SA true SG11201811070SA (en) 2019-01-30

Family

ID=60784697

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201811070SA SG11201811070SA (en) 2016-06-21 2017-06-21 Exosome-guided treatment of cancer

Country Status (11)

Country Link
US (1) US20190234955A1 (zh)
EP (1) EP3472623A4 (zh)
JP (1) JP2019527343A (zh)
KR (1) KR20190032374A (zh)
CN (1) CN109716135A (zh)
AU (1) AU2017280204A1 (zh)
CA (1) CA3027478A1 (zh)
IL (1) IL263835A (zh)
MX (1) MX2018015797A (zh)
SG (1) SG11201811070SA (zh)
WO (1) WO2017223186A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2972405A1 (en) 2014-12-30 2016-07-07 Dow Agrosciences Llc Use of picolinamide compounds as fungicides
TW201902357A (zh) * 2017-05-02 2019-01-16 美商陶氏農業科學公司 用作種子處理之無環吡啶醯胺
TWI724521B (zh) * 2018-08-30 2021-04-11 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 利用胞外囊泡診斷疾病的方法
US20230037966A1 (en) * 2020-01-07 2023-02-09 The Trustees Of The University Of Pennsylvania Source specific exosomes for determining avoidance of cancer treatment and avoidance of checkpoint inhibitor therapies
US20230142955A1 (en) * 2020-02-27 2023-05-11 The Trustees Of The University Of Pennsylvania Methods of using a multi-analyte approach for diagnosis and staging a disease
CN115449555B (zh) * 2022-10-26 2023-10-13 山东大学 Adgra2作为乳腺癌化疗疗效和预后评价生物标志物的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103300820A (zh) * 2012-03-13 2013-09-18 西门子公司 用于冠状动脉狭窄的非侵入性功能评估的方法和系统
WO2014028862A1 (en) * 2012-08-17 2014-02-20 Cornell University Use of dna in circulating exosomes as a diagnostic marker for metastasic disease
WO2014167969A1 (ja) * 2013-04-08 2014-10-16 塩野義製薬株式会社 大腸がんの検出方法
CN105431552B (zh) * 2013-04-12 2020-03-03 香港中文大学 多组学标记在预测糖尿病中的用途
HUE046489T2 (hu) * 2013-12-04 2020-03-30 Univ Texas Eljárás ráksejtekbõl származó exoszómák izolálására
JP6531171B2 (ja) * 2014-06-27 2019-06-12 エックスワイ エバーグリーン テクノロジー カンパニー Cns由来エクソソームを富化するための方法
CN104450901B (zh) * 2014-11-27 2016-09-21 广州赛哲生物科技股份有限公司 快速诊断川崎病的核酸标记物及其试剂盒

Also Published As

Publication number Publication date
EP3472623A1 (en) 2019-04-24
KR20190032374A (ko) 2019-03-27
CA3027478A1 (en) 2017-12-28
EP3472623A4 (en) 2020-01-15
MX2018015797A (es) 2019-05-16
WO2017223186A1 (en) 2017-12-28
JP2019527343A (ja) 2019-09-26
IL263835A (en) 2019-02-03
AU2017280204A1 (en) 2019-01-24
CN109716135A (zh) 2019-05-03
US20190234955A1 (en) 2019-08-01

Similar Documents

Publication Publication Date Title
HK1258098A1 (zh) 治療癌症的方法
HK1251409A1 (zh) 治療癌症的方法
IL260199B (en) Cancer treatment methods
IL261959A (en) Cancer treatment with tg02
PL3458052T3 (pl) Leczenie skojarzone nowotworu
IL259996A (en) Combinations for cancer treatment
IL265697B1 (en) Prostate cancer treatment
IL262342A (en) Cancer treatment methods
IL263835A (en) Exosome-guided treatment of cancer
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
GB201408297D0 (en) Treatment of cancer
HK1251794A1 (zh) 癌症治療
IL274748A (en) Improved cancer treatment
GB201417456D0 (en) Treatment of cancer
GB201622214D0 (en) treatment of cancer
GB201704287D0 (en) Treatment of cancer
GB201703857D0 (en) Treatment of cancer
GB201702565D0 (en) Treatment of cancer
GB201604621D0 (en) Treatment of cancer
GB201604293D0 (en) Treatment of cancer
GB201702139D0 (en) Methods of cancer treatment
GB201512723D0 (en) Treatment of cancer
GB201507928D0 (en) Treatment of cancer
GB201504617D0 (en) Treatment of cancer
GB201409362D0 (en) Treatment of cancer